Analyst Reco. BrainsWay Ltd.

Equities

BWAY

IL0011007189

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:02 2024-05-02 am EDT			5-day change	1st Jan Change
1,080 ^ILa	+5.68%		+11.01%	-6.01%

Apr. 17	Brainsway Expands Deep Tms Access in Israel Following Significant Increase in Reimbursement Rates	CI
Apr. 04	BrainsWay Ltd. Announces Publish Review Results Highlighting Potential of Deep Transcranial Magnetic Stimulation (Deep TMS?) as a Novel Therapeutic Approach for Parkinson's Disease	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Adjusts Price Target on Brainsway to $6 From $5.50, Maintains Outperform Rating	Nov. 16	MT
Raymond James Downgrades Brainsway to Market Perform From Outperform	Nov. 16	MT
BRAINSWAY : HC Wainwright Adjusts Brainsway's Price Target to $14 from $17, Keeps Buy Rating	21-08-12	MT
BRAINSWAY : HC Wainwright Initiates Brainsway at Buy Rating With $17 Price Target	21-07-19	MT
BRAINSWAY : Oppenheimer Adjusts Brainsway PT to $15 From $13 on Q4 Results & New Opportunities, Maintains Outperform Rating	21-03-26	MT
BRAINSWAY : Raymond James Adjusts Brainsway's Price Target to $12 From $9, Keeps Outperform Rating	21-02-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer